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standardized the oncology treatment fields available in the specific oncology data-
base (DataSUS AQ). Standardization included harmonization of different names 
used for the same drug name (i.e., cetuximab, cetux, cetukimabe and ketuxim), 
including generic and brand names. We also converted acronyms use in NCCN 
and MOC Brazil guidelines to the generic name (i.e.: fluoracil and 5FU; irinotecan 
and CPT-11). We created a new standardized table with additional fields (regimen 
name, drugs used, adjuvant therapy and a high/low cost flag). For this analysis we 
filtered by APAC (High complexity procedures approval) code for colorectal cancer 
(CRC) and lung cancer (LC) from 2012 to 2014. All blank or not identified regimens 
were excluded from this analysis. The final sample was composed by 50,729 CRC 
and 23,525 LC records. Results: It was compared the total number of regimens 
available at raw data and those standardized. Regarding CRC regimens we found 
7,698 different treatments in the raw database and 82 in the standardized dataset, 
a considerable reduction. In raw data, the most frequent regimen was FOLFOX rep-
resenting 7.9% of all records, in contrast to standardized dataset where FOLFOX 
regimen represented 33.6% of all records. We found 262 records written in differ-
ent ways in the raw database that referred to FOLFOX. Analyzing LC records, the 
most frequent regimen in raw data was carboplatin+taxo representing 3.1% of LC 
APACs claims in comparison to the standardized dataset where carboplatin+taxol 
represented 27.6% of all claims; 278 raw records had different names referring to 
carboplatin+taxol. ConClusions: DataSUS can be a reliable source on oncology 
consumption therapies after standardizing data fields that were originally intro-
duced by manual typing.
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objeCtives: Evaluate the possibility of extracting data from the EMR used by 
the Health Services of Colima, Mexico and use it to assess the quality of care 
and prescription patterns for Diabetes prevention and control in outpatient clin-
ics. Methods: A copy of the entire EMR database, including personal identifica-
tion variables, was obtained from the Health Services of Colima. A data verification 
and validation process was carried out including checking for EMR duplicity using 
Structured Query Language (SQL) and phonetic algorithms. A flat table for each 
patient’s encounter with the health services was constructed in order to have a 
longitudinal record along with vital signs, diagnostic and control tests as well as 
drugs prescribed. Each encounter was then coded to reflect in a single character 
string the main variables of diabetes care: number of visit after diagnosis, glucose 
measurement, drugs administered, as well as eye and feet examination. Results: 
The EMR in Colima initiated its operation in 2005 as a pilot in 3 clinics, in 2010 it 
covered about 50% of the state’s clinics (55) and in 2013 reached 100%: 117 clin-
ics. A total of 393,398 records were extracted and consolidated with 2,271,251 
outpatient visits in the period 2005 – march 2014. The age and sex structure of 
the population in the EMR was very similar to that of the 2010 population center 
for the state. Eleven percent of the population eighteen or older in the database 
was diagnosed with diabetes; only 45% of these had at least one glucose exam 
and only 16% were taking insulin. The most frequent medication prescribed was 
metformine. ConClusions: The use of data from EMR is suitable to evaluate 
quality of care and prescription patterns in the prevention and control of diabetes 
mellitus. Continuing monitoring established quality parameters and prescription 
may help to improve quality.
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objeCtives: To evaluate differences in social values collected in the Chilean 
EQ-5D valuations surveys of 2008 and 2013 using the time trade-off method 
(TTO). Methods: Responses from a total of 3701 individuals who participated in 
the 2008 and 2013 Chilean EQ-5D valuation surveys were analyzed to assess dif-
ferences in TTO values from 31 health states between both studies adjusting for 
gender, age and educational attendance. Differences were explored using several 
ordinary least square (OLS) regression models taking into account sampling weights. 
Variations of TTO values between the Metropolitan Region (MR) and the rest of the 
country were evaluated using data only from the 2013 survey adjusting not only 
for socio-demographic characteristics, but also for other variables known to have 
an effect on respondent´s values such as self-reported health status, marital status 
and level of difficulty answering the TTO questionnaire. Results: A basic regres-
sion model showed significant differences (p value < 0.001) between both surveys 
indicating that 2008´s TTO values collected only in the MR were lower than 2013´s 
TTO values collected alongside the whole country. These differences remain after 
adjusting for confounding variables. Exploring possible determinants of geographi-
cal differences at individual level based on 2013 data, only years of education and 
a high level of difficulty answering the TTO questionnaire appeared to have a sig-
nificant effect on valuations (p value < 0.001). However, those effects were marginal 
and do not fully explain the differences found between TTO values collected in the 
MR and the rest of the country. ConClusions: Our findings support the idea that 
cultural/geographical differences could have a significant impact on social values 
within-country. These differences constitute an important factor that should be 
taken into consideration when designing and analyzing results from these types 
of studies on a national level. Further international research is required to improve 
knowledge on this topic.
broadly similar to the Uruguayan population. Forty four percent of the subjects 
reported no problems on any of the five EQ-5D-5L dimensions. Older respondents 
reported more problems in all dimensions. Mean self-reported VAS was 79.63 
(SE 0.58); it decreased with age and was lower in women. As OLS model showed 
logical inconsistencies, robust modelling was chosen to derive social values. 
Values ranged from -0.264 to 1. States with a misery index= 6 had a mean value 
of 0.965. When comparing the prediction for a misery index= 6 in the Uruguayan 
population with the Argentinian EQ-5D-5L crosswalk value set, the Uruguay val-
ues are about 0.05 higher. The mean index value for the general population in 
Uruguay, using the final main effects Uruguayan EQ-5D-5L value set, is 0.895. In 
general, older people had worse values and males had slightly better values than 
females. ConClusions: We derived the EQ-5D-5L Uruguayan value set, the first 
in Latin America. These results will help inform decision-making using economic 
evaluations for resource allocation decisions.
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objeCtives: The aim of this study is to estimate the cost-effectiveness of cervical 
cancer primary screening with HPV PCR tests in Brazil. Methods: A Markov model 
captured the outcomes of 1,000 non-hysterectomized women ages 25 years and 
older who transitioned annually across possible health states and were screened 
over a 45-year period in Brazil. This model was used to compare three strategies: 
(1) cytology alone (2) Pooled HPV with reflex cytology (3) HPV with 16/18 genotyping 
and reflex cytology, from a payer’s perspective. The one-way and probabilistic sen-
sitivity analyses were performed. Additionally, the screening and cancer treatment 
costs were calculated according to DATASUS 2012 (Departamento de Informática do 
Sistema Único de Saúde - Brazil) public data, in Brazilian Real (BRL) and discounted 
at an annual rate of 5%. Results: The primary screening with the strategy (3) HPV 
with 16/18 genotyping and reflex cytology, results in earlier detection of clinically 
relevant high-grade CIN (Cervical Intraepithelial Neoplasia) at the initial visit along 
with efficient use of healthcare resource in Brazil. In addition, the model suggested 
an Incremental Cost Utility Ratio (ICUR) and Incremental Cost Effectiveness Ratio 
(ICER) of 13,266 R$/QALY and 51,389 R$/LYG, respectively, comparing the strategies 
(3) to (1), whereas, the strategy (2) was dominated by strategy (3). ConClusions: 
The current analysis indicated that the HPV with 16/18 genotyping test (strategy 3) 
is cost-effective for primary cervical cancer screening in women aged ≥ 25 years in 
Brazil due to the ICER ≤ 3 Brazilian GDP per capita, according to the World Health 
Organization’s recommendations.
PP4
an UndEvEloPEd PictURE: thE availability oF Utility valUations in 
latin aMERica – how will thEy aFFEct Qalys?
Montgomery S1, Stewart G2, Kusel J1
1Costello Medical Consulting Ltd, Cambridge, UK, 2Costello Medical Consulting Ltd., Cambridge, 
UK
objeCtives: Health Technology Appraisal processes in Latin American countries 
are of increasing importance. For decisions made on the basis of cost per qual-
ity-adjusted life year, the utility inputs used in the economic model are typically 
influential on the outcome. Utility valuations vary from country to country and we 
therefore sought to review the availability of valuations for Latin American coun-
tries. Methods: Using PubMed, a structured search was conducted to identify 
which of the common generic, preference-based instruments had valuations for 
Latin American countries. The instruments included in the search were EQ-5D, 
SF-6D and HUI. Identified studies were retrieved in full text and, where extant, 
valuations of each instrument across different countries were compared. Results: 
The review identified no HUI valuations, one SF-6D valuation (in Brazil) and three 
EQ-5D valuations (in Argentina, Chile and Brazil). The three EQ-5D valuations all 
used time trade-off methodology but the sampled states used differed such that 
only 13 states had an observed value across all three studies. Visual comparison 
of these observed states revealed considerable divergence of the Chilean valuation 
from the Brazilian and Argentinian valuations in the lower health states. This trend 
remained when the final modelled values for the full set of EQ-5D health states were 
plotted. Divergence increased in worse states, producing greater utility differences 
between states in Chile. ConClusions: There are currently a limited number of 
valuation sets available in Latin America. Only EQ-5D has multiple valuations to 
allow inter-country comparison, revealing clear differences. Such noticeable varia-
tions between countries in the value of changing health states make it unlikely that 
cost-utility analyses are generalisable in the region, affecting pricing and reimburse-
ment decisions. Further work therefore remains to generate valuation sets for other 
countries in Latin America to allow an understanding of how reimbursement may 
be affected by increasing use of HTA.
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objeCtives: To compare results of oncology drugs consumption extracted from 
DataSUS raw database with those obtained after standardizing and cleaning data-
base fields. Methods: We used the SUS database available from DataSUS FTP and 
